Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7913)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Aug 15, 2020 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Yan Y, Lin HW, Zhuang ZN, Li M, Guo S. Interleukin-1 receptor antagonist enhances chemosensitivity to fluorouracil in treatment of Kras mutant colon cancer. World J Gastrointest Oncol 2020; 12(8): 877-892 [PMID: 32879665 DOI: 10.4251/wjgo.v12.i8.877] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v12/i8/877.htm |
| Number | Citing Articles |
| 1 |
Shyng-Shiou F. Yuan, Yun-Ming Wang, Leong-Perng Chan, Amos C. Hung, Hieu D. H. Nguyen, Yuk-Kwan Chen, Stephen Chu‐Sung Hu, Steven Lo, Yen-Yun Wang. IL-1RA promotes oral squamous cell carcinoma malignancy through mitochondrial metabolism-mediated EGFR/JNK/SOX2 pathway. Journal of Translational Medicine 2023; 21(1) doi: 10.1186/s12967-023-04343-9
|
| 2 |
Zhiguo Jiang, Zaixing Yang. Comments on: Acute aerobic exercise‐conditioned serum reduces colon cancer cell proliferation in vitro through interleukin‐6‐induced regulation of DNA damage. International Journal of Cancer 2022; 151(9): 1640 doi: 10.1002/ijc.34175
|
| 3 |
Ahmed Hjazi, Faryal Nasir, Rabia Noor, Ali Alsalamy, Rahman S. Zabibah, Rosario Mireya Romero-Parra, Muhammad Ikram Ullah, Yasser Fakri Mustafa, Maytham T. Qasim, Shaik Vaseem Akram. The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics. Pathology - Research and Practice 2023; 248: 154616 doi: 10.1016/j.prp.2023.154616
|
| 4 |
Marzia Spagnardi, Jenny Paredes, Jovanny Zabaleta, Jone Garai, Tiana Reyes, Laura A. Martello, Jennie L. Williams. IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.1010380
|
| 5 |
Kelly M. Herremans, Patrick W. Underwood, Andrea N. Riner, Daniel W. Neal, Gerik W. Tushoski-Alemán, Christopher E. Forsmark, Ibrahim Nassour, Song Han, Steven J. Hughes. A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarcinoma. Pancreatology 2023; 23(6): 615 doi: 10.1016/j.pan.2023.06.007
|